Drug Type Radiolabeled antibody, Fab fragment, Diagnostic radiopharmaceuticals |
Synonyms Arcitumomab, Arcitumomab technetium-99m, ImmuRAID-CEA + [10] |
Target |
Action inhibitors |
Mechanism CEA inhibitors(Carcinoembryonic antigen inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date European Union (04 Oct 1996), |
RegulationOrphan Drug (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Arcitumomab technetium-99m |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Colorectal Cancer | European Union | 04 Oct 1996 | |
Colorectal Cancer | Iceland | 04 Oct 1996 | |
Colorectal Cancer | Liechtenstein | 04 Oct 1996 | |
Colorectal Cancer | Norway | 04 Oct 1996 |